Journal of Prevention and Treatment for Stomatological Diseases ›› 2021, Vol. 29 ›› Issue (4): 260-266.doi: 10.12016/j.issn.2096-1456.2021.04.007

• Review Articles • Previous Articles     Next Articles

Research progress on biomarkers related to radiotherapy and/or chemotherapy-induced oral mucositis

LING Yunxiao1(),WANG Jiantao2,WANG Yan1()   

  1. 1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, Department of Pediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
    2. State Key Laboratory of Biotherapy & Department of Lung Cancer Center and Department of Radiation Oncology, West China Hospital, Sichuan University, Chengdu 610041, China
  • Received:2020-01-16 Revised:2020-05-13 Online:2021-04-20 Published:2021-02-26
  • Contact: Yan WANG E-mail:877518113@qq.com;wangyan1458@163.com
  • Supported by:
    National Natural Science Foundation of China(81600864);Sichuan Provincial Commision of Health and Family Planning Fund Promotion Program(18PJ186)

Abstract:

Radiotherapy and/or chemotherapy-induced oral mucositis is a common oral complication in tumor patients undergoing radiotherapy and/or chemotherapy, which seriously compromises patients’ quality of life and even affects anti-tumor treatment. Biomarkers are signal indicators that appear at different biological levels before or during disease. A comprehensive understanding of the biomarkers associated with oral mucositis contributes to the early identification of high-risk patients with oral mucositis and aids in the screening of patients prone to develop severe oral mucositis, guiding the prevention and treatment of oral mucositis. This article reviews the existing biomarkers associated with oral mucositis. The literature review results showed that the biomarkers associated with oral mucositis included growth factors, inflammatory cytokines, genes, plasma antioxidants, and pro-apoptotic proteins/inhibitor of apoptosis proteins. These biomarkers can be used to predict the risk of oral mucositis or facilitate early discrimination of patients prone to exhibit severe radiotherapy and/or chemotherapy-induced oral mucositis. EGF, TNF-α, IL-6, IL-1β and CRP can be used to predict and evaluate the risk and development of oral mucositis, whereas genes such as excision repair cross complementing 1(ERCC1), X-ray repair cross complementing 1(XRCC1), methylenetetrahydrofolate reductase (MTHFR) and tumor necrosis factor receptor superfamily member 1A (TNFRSF1A) have been focus of research in recent years. The genotypes and expression levels of some of these genes exhibit variable capacities to predict the risk and severity of oral mucositis. However, no biomarkers have been used in clinical practice, and more studies are needed in the future to verify the reliability and accuracy of these biomarkers, to provide a reference for the early accurate prevention and treatment of radiation and chemotherapy oral mucositis.

Key words: oral mucositis, radiotherapy and/or chemotherapy-induced oral mucositis, radiotherapy, chemotherapy, biomarkers, epidermal growth factor, vascular endothelial growth factor, basic fibroblast growth factor, tumor necrosis factor-α, interleukin, excision repair cross complementing 1, X-ray repair cross complementing 1, methylenetetrahydrofolate reductase

CLC Number: 

  • R86
[1] Thomsen M, Vitetta L. Adjunctive treatments for the prevention of chemotherapy- and Radiotherapy-Induced mucositis[J]. Integr Cancer Ther, 2018,17(4):1027-1047. doi: 10.1177/1534735418794885.
pmid: 30136590
[2] Sá OMS, Lopes NNF, Alves MTS, et al. Effects of glycine on collagen, PDGF, and EGF expression in model of oral mucositis[J]. Nutrients, 2018,10(10):1485. doi: 10.3390/nu10101485.
[3] Normando AG, Rocha CL, De Toledo IP, et al. Biomarkers in the assessment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis[J]. Support Care Cancer, 2017,25(9):2969-2988. doi: 10.1007/s00520-017-3783-8.
pmid: 28623401
[4] Dote S, Itakura S, Kamei K, et al. Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study[J]. BMC Cancer, 2018,18(1):957. doi: 10.1186/s12885-018-4862-z.
doi: 10.1186/s12885-018-4862-z pmid: 30290786
[5] Principe S, Dikova V, Bagán J. Salivary cytokines in patients with head and neck cancer (HNC) treated with radiotherapy[J]. J Clin Exp Dent, 2019,11(11):e1072-e1077. doi: 10.4317/jced.56318.
doi: 10.4317/jced.56318 pmid: 31700580
[6] Kim JW, Kim MG, Lee HJ, et al. Topical recombinant human epidermal growth factor for oral mucositis induced by intensive chemotherapy with hematopoietic stem cell transplantation: final analysis of a randomized, Double-Blind, Placebo-Controlled, phase 2 trial[J]. PLoS One, 2017,12(1):e0168854-e0168854. doi: 10.1371/journal.pone.0168854.
doi: 10.1371/journal.pone.0168854 pmid: 28045958
[7] Luo J, Bian L, Blevins M, et al. Smad7 promotes healing of Radiotherapy-Induced oral mucositis without compromising oral cancer therapy in a xenograft mouse model[J]. Clin Cancer Res, 2019,25(2):808-818. doi: 10.1158/1078-0432.CCR-18-1081.
doi: 10.1158/1078-0432.CCR-18-1081 pmid: 30185419
[8] Chicharro-Alcántara D, Rubio-Zaragoza M, Damiá-Giménez E, et al. Platelet rich plasma: new insights for cutaneous wound healing management[J]. J Funct Biomater, 2018,9(1):10. doi: 10.3390/jfb9010010.
doi: 10.3390/jfb9010010
[9] Russo N, Bellile E, Murdoch-Kinch CA, et al. Cytokines in saliva increase in head and neck cancer patients after treatment[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2016, 122(4): 483-490.e1. doi: 10.1016/j.oooo.2016.05.020.
doi: 10.1016/j.oooo.2016.05.020 pmid: 27554375
[10] Maria OM, Eliopoulos N, Muanza T. Radiation-Induced oral mucositis[J]. Front Oncol, 2017,7:89. doi: 10.3389/fonc.2017.00089.
doi: 10.3389/fonc.2017.00089 pmid: 28589080
[11] 邱好妙. 猪胆青黛冰硼散联合rhG-CSF对鼻咽癌放射性口腔黏膜炎患者口腔微循环、唾液和血清炎性细胞因子的影响[J]. 现代中西医结合杂志, 2018,27(30):3383-3386. doi: 10.3969/j.issn.1008-8849.2018.30.024.
Qiu HM. Effects of porcine choleqingdebing boron powder combined with rhg-CSF on oral microcirculation, saliva and serum inflammatory cytokines in patients with nasopharyngeal carcinoma with radioactive oral mucositis[J]. Mod J Integr Trad Chin West Med, 2018,27(30):3383-3386. doi: 10.3969/j.issn.1008-8849.2018.30.024.
[12] Cinausero M, Aprile G, Ermacora P, et al. New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury[J]. Front Pharmacol, 2017,8:354. doi: 10.3389/fphar. 2017.00354.
doi: 10.3389/fphar.2017.00354 pmid: 28642709
[13] Mlak R, Tomasz P, Brzozowska A, et al. The relationship between TNF-α gene promoter polymorphism (- 1211 T > C), the plasma concentration of TNF-α, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck[J]. Support Care Cancer, 2020,28(2):531-540. doi: 10.1007/s00520-019-04838-6.
doi: 10.1007/s00520-019-04838-6 pmid: 31076897
[14] 李春阳, 陈小华, 陶小安, 等. 大鼠放射性口腔黏膜炎病损组织细胞因子检测及意义[J]. 中山大学学报(医学科学版), 2010,31(2):231-237.
Li CY, Chen XH, Tao XA. Investigation and significance of cytokines in local tissues of radiation-induced oral mucositis in a rat model[J]. J Sun Yat-sen Univ (Med Sci), 2010,31(2):231-237.
[15] Bossi P, Bergamini C, Miceli R, et al. Salivary cytokine levels and oral mucositis in head and neck cancer patients treated with chemotherapy and radiation therapy[J]. Int J Radiat Oncol Biol Phys, 2016,96(5):959-966. doi: 10.1016/j.ijrobp.2016.08.047.
doi: 10.1016/j.ijrobp.2016.08.047 pmid: 27745982
[16] 张纪良, 青晓燕, 兰曦. 重组人白介素-11治疗鼻咽癌放化疗所致急性口腔黏膜炎疗效观察[J]. 中国现代医生, 2016,54(11):79-81, 85.
Zhang JL, Qing XY, Lan X. Efficacy observation of recombinant human interleukin-11 in acute oral mucositisin patients with nasopharyngeal carcinoma caused by concurrent chemoradiotherapy[J]. Chin Mod Doctor, 2016,54(11):79-81, 85.
[17] Dacewicz MP, Dudziak MS, Dworzański J, et al. Salivary and serum IL-10, TNF-α, TGF-β, VEGF levels in oropharyngeal squamous cell carcinoma and correlation with HPV and EBV infections[J]. Infect Agents Cancer, 2016,11:45. doi: 10.1186/s13027-016-0093-6.
doi: 10.1186/s13027-016-0093-6
[18] Reyes-Gibby CC, Melkonian SC, Jian W, et al. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: an informative gene network analysis[J]. Plos One, 2017,12(7):e0180396. doi: 10.1371/journal.pone.0180396.
doi: 10.1371/journal.pone.0180396 pmid: 28678827
[19] Yu X, Xiao H, Zhao B, et al. DNA repair gene ERCC1 C118T polymorphism predicts sensitivity of recurrent esophageal cancer to radiochemotherapy in a Chinese population[J]. Thorac Cancer, 2015,6(6):741-748. doi: 10.1111/1759-7714.12251.
doi: 10.1111/1759-7714.12251 pmid: 26557912
[20] Mlak R, Powrózek T, Brzozowska A, et al. RRM1 gene expression evaluated in the liquid biopsy (blood cfRNA) as a non-invasive, predictive factor for radiotherapy-induced oral mucositis and potential prognostic biomarker in head and neck cancer patients[J]. Cancer Biomark, 2018,22(4):657-667. doi: 10.3233/CBM-171082.
doi: 10.3233/CBM-171082 pmid: 29865035
[21] Viet CT, Corby PM, Akinwande A, et al. Review of preclinical studies on treatment of mucositis and associated pain[J]. J Dent Res, 2014,93(9):868-875. doi: 10.1177/0022034514540174.
doi: 10.1177/0022034514540174
[22] Brzozowska A, Mlak R, Homa-Mlak I, et al. Polymorphism of regulatory region of APEH gene (c.-521G>C, rs4855883) as a relevant predictive factor for radiotherapy induced oral mucositis and overall survival in head neck cancer patients[J]. Oncotarget, 2018,9(51):29644-29653. doi: 10.18632/oncotarget.25662.
doi: 10.18632/oncotarget.25662 pmid: 30038710
[23] Brzozowska A, Homa-Mlak I, Mlak R, et al. Polymorphism of regulatory region of GHRL gene (-2531C>T) as a promising predictive factor for radiotherapy-induced oral mucositis in patients with head neck cancer[J]. Head Neck, 2018,40(8):1799-1811. doi: 10.1002/hed.25154.
doi: 10.1002/hed.25154 pmid: 29566446
[24] Marcussen M, Sønderkær M, Bødker JS, et al. Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma[J]. PLoS One, 2018,13(1):e0190709. doi: 10.1371/journal.pone.0190709.
doi: 10.1371/journal.pone.0190709 pmid: 29338018
[25] Sardaro N, Della VF, Incalza MA, et al. Oxidative stress and oral mucosal diseases: an overview[J]. In Vivo, 2019,33(2):289-296. doi: 10.21873/invivo.11474.
doi: 10.21873/invivo.11474 pmid: 30804105
[26] Borys J, Maciejczyk M, Antonowicz B, et al. Glutathione metabolism, mitochondria activity, and nitrosative stress in patients treated for mandible fractures[J]. J Clin Med, 2019,8(1):127. doi: 10.3390/jcm8010127.
doi: 10.3390/jcm8010127
[27] Jesija JS, Gopal S, Skiel HP. Recurrent aphthous stomatitis: an assessment of antioxidant levels in plasma and saliva[J]. J Clin Diagn Res, 2017, 11(9): ZC64-ZC67. doi: 10.7860/JCDR/2017/29065.10624.
doi: 10.7860/JCDR/2017/29065.10624 pmid: 29207836
[28] Zhang Z, Li S, Fang HQ. Enzymatic antioxidants status in patients with recurrent aphthous stomatitis[J]. J Oral Pathol Med, 2017,46(9):817-820. doi: 10.1111/jop.12547.
doi: 10.1111/jop.12547 pmid: 28054386
[29] Nejatinamini S, Debenham BJ, Clugston RD, et al. Poor vitamin status is associated with skeletal muscle loss and mucositis in head and neck cancer patients[J]. Nutrients, 2018,10(9):1236. doi: 10.3390/nu10091236.
[30] Ding L, Li JW, Li WH, et al. p53-and ROS-mediated AIF pathway involved in TGEV-induced apoptosis[J]. J Vet Med Sci, 2018,80(11):1775-1781. doi: 10.1292/jvms.18-0104.
doi: 10.1292/jvms.18-0104 pmid: 30249935
[31] Lalaoui N, Vaux DL. Recent advances in understanding inhibitor of apoptosis proteins[J]. F1000Res, 2018,7:1889. doi: 10.12688/f1000research.16439.1.
doi: 10.12688/f1000research
[32] Anderton H, Rickard JA, Varigos GA, et al. Inhibitor of apoptosis proteins (IAPs) limit RIPK1-mediated skin inflammation[J]. J Invest Dermatol, 2017,137(11):2371-2379. doi: 10.1016/j.jid.2017. 05.031.
doi: 10.1016/j.jid.2017.05.031 pmid: 28647349
[33] Krause CE, Otieno B, Bishop GW, et al. Ultrasensitive microfluidic array for serum pro-inflammatory cytokines and C-reactive protein to assess oral mucositis risk in cancer patients[J]. Anal Bioanal Chem, 2015,407(23):7239-7243. doi: 10.1007/s00216-015-8873-1.
doi: 10.1007/s00216-015-8873-1 pmid: 26143063
[34] Wang H, Wang Z, Huang Y, et al. Senolytics (DQ) mitigates radiation ulcers by removing senescent cells[J]. Front Oncol, 2020,9:1576. doi: 10.3389/fonc.2019.01576.
doi: 10.3389/fonc.2019.01576 pmid: 32117790
[35] Ardito F, Giuliani M, Perrone D, et al. Expression of salivary biomarkers in patients with oral mucositis: evaluation by SELDI-TOF/MS[J]. Oral Dis, 2016,22(3):209-219. doi: 10.1111/odi.12405.
doi: 10.1111/odi.12405 pmid: 26613366
[1] ZHANG Lin,TANG Yawen,WANG Jiantao,WANG Yan. Research progress on probiotics for the prevention and treatment of oral and gastrointestinal chemoradiotherapy mucositis [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(8): 567-571.
[2] TANG Yawen,ZHANG Lin,YANG Xue,ZOU Jing,WANG Yan. Oral health management in children with acute lymphoblastic leukemia [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(8): 572-576.
[3] SHAN Chao,WANG Tingting,ZHAO Jin. Research progress on the correlation between interleukin-18 and chronic periodontitis [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(7): 485-489.
[4] ZHANG Shuguang,YIN Xiteng,XU Wenguang,HAN Wei,LIU Zhe. Clinical analysis of 22 cases of lymphoepithelial carcinoma of parotid gland [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(6): 400-405.
[5] GU Wenjia,LU Haixia,ZHANG Yu,FENG Xiping. Research progress on the study of the relationship between periodontitis and cancers of the digestive system [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(5): 346-350.
[6] WANG Ziying,CHEN Xiaotao. Research progress on the role of T helper cells 17 and interleukin 17 in oral mucosal diseases [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(3): 194-197.
[7] JI Ling,WANG Jiahe,WANG Jiantao,Wang Yan. The role of Toll-like receptors in chemoradiotherapy-induced gastrointestinal mucositis [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(2): 124-129.
[8] WANG Anxun. Detection and significance of immune function in oral mucosa-associated diseases [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(2): 73-80.
[9] ZHANG Qian,CHEN Bin,YAN Fuhua. Changes and clinical significance of four biomarkers in gingival crevicular fluid after nonsurgical periodontal therapy [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(12): 828-835.
[10] YANG Hui,WANG Xiang,ZHANG Lei,WANG Wenmei,DUAN Ning,LI Ruowei,ZHANG Miaomiao. Clinical analysis of 19 cases of oral mucosal malignant melanoma [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(12): 843-847.
[11] SUN Zhongyi,CHEN Yiming,WANG Yi,JI Tong. 55 cases of perioperative mortality in oral maxillofacial head and neck cancer patients: a retrospective analysis [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(9): 575-580.
[12] LIU Enyan,HE Bing,LI Mingyun. Research progress on epigallocatechin-3-gallate in the prevention and treatment of oral cancer [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(7): 468-471.
[13] ZOU Xiaolong,CHEN Yuan,WANG Yan,WANG Jiantao. Research progress on animal models of oral mucositis caused by radiotherapy and chemotherapy [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(5): 322-326.
[14] LIN Xiaoping,HAN Yakun. The role of B cell osteoimmunity in periodontitis [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(4): 205-213.
[15] DING Feng,SHI Shaojie,SONG Yingliang. Research progress of superhydrophilic implants [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(4): 252-256.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] ZHU Song-song, HU Jing. The application of distraction osteogenesis in the temporomandibular joint ankylosis and secondary dentofacial deformities[J]. journal1, 2016, 24(1): 6 -10 .
[2] XU Jing. The influence of the impacted mandibular third molar extraction on the distal periodontal tissue of the mandibular second molar[J]. journal1, 2016, 24(1): 11 -14 .
[3] ZHONG Jiang-long, PAN Ji-yang, CHEN Wei-liang. The evaluation of Eagle syndrome treatment by surgery combined with antidepressant therapy[J]. journal1, 2016, 24(1): 26 -28 .
[4] CHEN Xi, SUN Qin-zhou. The study of colorimetric board of porcelain fused to metal restoration for moderate to severe dental fluorosis[J]. journal1, 2016, 24(1): 33 -36 .
[5] OUYANG Ke-xiong1, LIANG Jun, ZOU Rui, LI Zhi-qiang, BAI Zhi-bao, PIAO Zheng-guo, ZHAO Jian-Jiang.. Ion Torrent RNA-Seq detection and analysis of the long non-coding RNA in tongue squamous cell carcinoma[J]. journal1, 2016, 24(1): 15 -19 .
[6] YU Pei, XUE Jing, ZHANG Xiao-wei, ZHENG Cang-shang. The influence of the roughness of zirconia ceramic surface on microbial attachment[J]. journal1, 2016, 24(1): 20 -25 .
[7] LIU Fang. Clinical assessment of two fissure sealant techniques in children’s dental caries prevention[J]. journal1, 2016, 24(1): 44 -45 .
[8] . [J]. journal1, 2016, 24(1): 49 -52 .
[9] LU Jian-rong, BAN Hua-jie, WANG Dai-you, ZHOU Hui-hui, LONG Ru, QIN Shu-hua. Clinical observation of sternocleidomastoid muscle flaps combined with artificial biological membrane reparing the defects after parotidectomy[J]. journal1, 2016, 24(1): 29 -32 .
[10] LI Bin, HE Xiao-ning, GAO Yuan, HU Yu-ping. Clinical analysis of pain after two kinds of apical stop preparation[J]. journal1, 2016, 24(1): 40 -43 .
This work is licensed under a Creative Commons Attribution 3.0 License.